29 General introduction j.1468-1331.2003.00571.x 113. Gerhard A, et al. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology. Sep 9 2003;61(5):686-9. doi:10.1212/01.wnl.0000078192.95645.e6 114. Gerhard A, et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson’s disease. Neurobiol Dis. Feb 2006;21(2):404-12. doi:10.1016/j.nbd.2005.08.002 115. Gerhard A, et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy. Mov Disord. Jan 2006;21(1):8993. doi:10.1002/mds.20668 116. Gerhard A, et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in corticobasal degeneration. Mov Disord. Oct 2004;19(10):1221-6. doi:10.1002/mds.20162 117. Ghadery C, et al. Microglial activation in Parkinson’s disease using [(18)F]-FEPPA. J Neuroinflammation. Jan 11 2017;14(1):8. doi:10.1186/s12974-0160778-1 118. Groom GN, et al. PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer’s disease. J Nucl Med. Dec 1995;36(12):2207-10. 119. Henkel K, et al. Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration. Mov Disord. Jul 2004;19(7):817-821. doi:10.1002/mds.20040 120. Politis M, et al. Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington’s disease gene carriers. Neurobiol Dis. Nov 2015;83:115-21. doi:10.1016/j.nbd.2015.08.011 121. Tai YF, et al. Imaging microglial activation in Huntington’s disease. Brain Res Bull. Apr 30 2007;72(2-3):148-51. doi:10.1016/j. brainresbull.2006.10.029 122. Tomasi G, et al. Novel reference regionmodel reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer’s disease. J Nucl Med. Aug 2008;49(8):1249-56. doi:10.2967/jnumed.108.050583 123. Venneti S, et al. PK11195 labels activated microglia in Alzheimer’s disease and in vivo in a mouse model using PET. Neurobiol Aging. Aug 2009;30(8):121726. doi:10.1016/j.neurobiolaging.2007.11.005 124. Yankam Njiwa J, et al. Quantitative longitudinal imaging of activated microglia as a marker of inflammation in the pilocarpine rat model of epilepsy using [(11)C]-( R)-PK11195 PET and MRI. J Cereb Blood Flow Metab. Apr 2017;37(4):12511263. doi:10.1177/0271678X16653615 125. Arlicot N, et al. Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation. Eur J Nucl Med Mol Imaging. Dec 2008;35(12):2203-11. doi:10.1007/ s00259-008-0834-x 126. Dickens AM, et al. Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180. J Nucl Med. Mar 2014;55(3):466-72. doi:10.2967/ jnumed.113.125625 127. Domene A, et al. Expression of Phenotypic Astrocyte Marker Is Increased in a Transgenic Mouse Model of Alzheimer’s Disease versus Age-Matched Controls: A Presymptomatic Stage Study. Int J Alzheimers Dis. 2016;2016:5696241. doi:10.1155/2016/5696241 128. Israel I, et al. Combined [(18)F]DPA-714 micropositron emission tomography and autoradiography imaging of microglia activation after closed head injury in mice. journal article. J Neuroinflammation. Jun 7 2016;13(1):140. doi:10.1186/s12974-0160604-9 129. Ji B, et al. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses inmouse models of Alzheimer’s and other CNS pathologies. J Neurosci. Nov 19 2008;28(47):12255-67. doi:10.1523/ JNEUROSCI.2312-08.2008 130. Lavisse S, et al. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J Neurosci. Aug 8 2012;32(32):10809-18. doi:10.1523/ JNEUROSCI.1487-12.2012 131. Lavisse S, et al. [18F]DPA-714 PET imaging of translocator protein TSPO (18 kDa) in the normal and excitotoxically-lesioned nonhuman primate brain. Eur J Nucl Med Mol Imaging. Mar 2015;42(3):478-94. doi:10.1007/s00259-0142962-9 132.Maeda J, et al. Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor. Brain Res. Jul 9 2007;1157:100-11. doi:10.1016/j.brainres.2007.04.054 133.Mattner F, et al. Evaluation of [(1)(2)(3)I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation. Eur J Nucl Med Mol Imaging. Aug 2011;38(8):1516-28. doi:10.1007/s00259-0111784-2 134.Nguyen DL, et al. Longitudinal positron emission tomography imaging of glial cell activation in a mouse model of mesial temporal lobe epilepsy: Toward identification of optimal treatment windows. Epilepsia. Jun 2018;59(6):1234-1244. doi:10.1111/epi.14083 135. Rojas S, et al. Imaging brain inflammation with [(11)C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats. J Cereb Blood Flow Metab. Dec 2007;27(12):1975-86. doi:10.1038/ sj.jcbfm.9600500 136. Serriere S, et al. Amyloid load and translocator protein 18 kDa in APPswePS1-dE9 mice: a longitudinal study. Neurobiol Aging. Apr 2015;36(4):1639-1652. doi:10.1016/j.
RkJQdWJsaXNoZXIy MTk4NDMw